Supernumerary isochromosome 1, idic(1)(p12), leading to tetrasomy 1q in Burkitt lymphoma

Cytogenet Genome Res. 2014;142(1):7-13. doi: 10.1159/000355985. Epub 2013 Nov 8.

Abstract

Burkitt lymphoma (BL) is an aggressive mature B-cell neoplasm. The cytogenetic hallmark are MYC-involving translocations, most frequently as t(8;14)(q24;q32). Additional cytogenetic abnormalities are seen in the majority of cases. The most frequent additional aberration involves the long arm of chromosome 1, either as partial or complete trisomy 1q. A very rare additional aberration is a supernumerary isochromosome 1q, i(1)(q10), resulting in tetrasomy 1q. The biological significance of this aberration is unclear. We present a highly aggressive case of BL in a child with immature B-cell immunophenotype (IP) and supernumerary i(1)(q10). Diagnostic karyotyping showed 47,XY,+i(1)(q10),t(8;14)(q24;q32)[2]/47,idem,del(15)(q24)[21]/46,XY[2]. aCGH analysis detected a gain of 1p12qter and a loss of 15q22q25. FISH analysis confirmed the isodicentric chromosome 1, which has not previously been reported in BL. In the literature, supernumerary i(1)(q10) was found in 11 cases of which >80% presented with immature B-cell IP and >60% relapsed or died. Tetrasomy 1q resulting from supernumerary idic(1)(p12) or i(1)(q10) is a rare genetic event in BL and probably associated with immature B-cell IP. We propose that high amplification of genes on chromosome 1p12qter may contribute to the BL IP and disease progression.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • B-Lymphocytes / chemistry
  • B-Lymphocytes / pathology
  • Bone Marrow / pathology
  • Burkitt Lymphoma / diagnosis
  • Burkitt Lymphoma / drug therapy
  • Burkitt Lymphoma / genetics*
  • Burkitt Lymphoma / pathology
  • Burkitt Lymphoma / surgery
  • Child
  • Chromosome Banding
  • Chromosomes, Human, Pair 1 / genetics
  • Chromosomes, Human, Pair 1 / ultrastructure*
  • Combined Modality Therapy
  • Comparative Genomic Hybridization
  • Diagnostic Errors
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunophenotyping
  • In Situ Hybridization, Fluorescence
  • Isochromosomes* / genetics
  • Male
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Recurrence
  • Sequence Deletion
  • Tetrasomy*
  • Translocation, Genetic